Here, we investigate if CDDO-Me reprograms tumor-associated macrophages in a Nrf2-dependent manner to create an anti-tumor immune microenvironment in a carcinogen-induced model of preclinical lung cancer. The gene discussed is NFE2L2; the disease is neoplasm.